SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow

Skin Laxity Clinical Trial

Official title:

Safety and Efficacy of Sofacia Treatment to Improve Facial Lines and Wrinkles, to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04969380
• Other study ID #: UCI IRB HS# 2019-5520
• Status: Completed
• Phase: N/A
• Start date: February 27, 2020
• Est. completion date: February 27, 2023

Study information

• Verified date: October 2021
• Source: Sofwave Medical LTD
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.

Description:

Eligible patients will receive 2 face and neck treatments (4-6 weeks ± 2 weeks apart) using the SofWave System. Each investigational site would treat the full face and submental zones including 1. The forehead and temples (left and right including the peri orbital zone) to lift the eyebrows 2. The cheeks (left and right including perioral zone and nasolabial folds)

3. Submental and sides of the neck (left and right) to lift lax skin.

All patients will return to the clinic for two follow up visits: 1. 7 days (FU1) post the first treatment (Tx.1). 2. 3 months ± 2 weeks post last treatment (FU2).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: February 27, 2023
• Est. primary completion date: February 27, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 35 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Healthy female and male subjects between the ages 35-80.

2. Non-Smoker.

3. Fitzpatrick skin type I-VI.

4. Desire to lift lax skin in the neck and submental and/or to lift the brows.

5. Able and willing to comply with all visit, treatment and evaluation schedules and requirements.

6. Able to understand and provide written Informed Consent

7. Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment.

Exclusion Criteria:

1. Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding.

2. Presence of any active systemic or local infections.

3. Presence of active local skin disease that may alter wound healing.

4. Severe solar elastosis.

5. History of smoking in past 10 years.

6. History of chronic drug or alcohol abuse.

7. Excessive subcutaneous fat on the cheeks.

8. Significant scarring in the area to be treated.

9. Severe or cystic facial acne, acutance uses during past 6 months.

10. Presence of a metal stent or implant in the facial area (dental implants and/or braces are not excluded).

11. Inability to understand the protocol or to give informed consent.

12. History of cosmetic treatments in the facial area to be treated, including facial skin-tightening procedure within the 6 months ; injectable (Botox or fillers) of any type within the 6 months; ablative or non-ablative resurfacing/rejuvenation laser treatment or light treatment within the past 6 months, dermabrasion or deep facial peels within the past 12 months; facelift, blepharoplasty, or brow lift (including contour threads) within the past 12 months.

13. Taking Isotretinoin or other oral retinoid within the past 6 months; taking anti-platelet or anti-coagulant within the past 2 weeks.

14. As per the investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.

Related Conditions & MeSH terms

• Cutis Laxa
• Skin Laxity

Intervention

Device:
• Sofwave
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.

Locations

Country	Name	City	State
United States	University of California	Irvine	California

Sponsors (1)

Lead Sponsor	Collaborator
Sofwave Medical LTD

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in lift of lax tissue	As assessed by independent masked evaluators. Quantitative image analysis to objectively measure change in lift of the eyebrow and submental and neck lax tissue would be conducted by comparing baseline images to those taken at each visit post FU1 (Pre Tx.2, FU2)	3 and 6 months post last treatment